MENU
+Compare
CNTA
Stock ticker: NASDAQ
AS OF
Oct 24 closing price
Price
$24.15
Change
+$0.01 (+0.04%)
Capitalization
3.24B

CNTA Centessa Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company... Show more

CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CNTA with price predictions
Oct 24, 2025

Aroon Indicator for CNTA shows an upward move is likely

CNTA's Aroon Indicator triggered a bullish signal on October 09, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 166 similar instances where the Aroon Indicator showed a similar pattern. In of the 166 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2025. You may want to consider a long position or call options on CNTA as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNTA advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CNTA moved out of overbought territory on October 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for CNTA turned negative on October 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNTA broke above its upper Bollinger Band on October 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.390) is normal, around the industry mean (24.402). P/E Ratio (0.000) is within average values for comparable stocks, (54.668). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.161). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (208.333) is also within normal values, averaging (355.249).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CNTA is expected to report earnings to rise 2.18% to -38 cents per share on November 17

Centessa Pharmaceuticals plc CNTA Stock Earnings Reports
Q3'25
Est.
$-0.39
Q2'25
Missed
by $0.05
Q1'25
Beat
by $0.16
Q4'24
Missed
by $0.42
Q3'24
Beat
by $0.03
The last earnings report on August 12 showed earnings per share of -37 cents, missing the estimate of -32 cents. With 316.32K shares outstanding, the current market capitalization sits at 3.24B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Ashley Road
Phone
+1 617 468-5770
Employees
153
Web
https://www.centessa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VFTNX46.910.41
+0.88%
Vanguard FTSE Social Index I
FOBPX21.390.09
+0.42%
Tributary Balanced Instl Plus
PPSFX22.220.08
+0.36%
Principal Large Cap Value III R3
CSUAX25.26-0.01
-0.04%
Cohen & Steers Global Infrastructure A
MLXAX24.93-0.24
-0.95%
Catalyst Energy Infrastructure A

CNTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with ROIV. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
+0.04%
ROIV - CNTA
43%
Loosely correlated
+0.55%
CLDX - CNTA
42%
Loosely correlated
+1.75%
VRDN - CNTA
42%
Loosely correlated
+0.41%
NUVL - CNTA
41%
Loosely correlated
+2.75%
RVMD - CNTA
39%
Loosely correlated
+1.95%
More